What is circulating tumor DNA (ctDNA) in prostate cancer? Learn how this blood test helps track disease and guide treatment.

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

A British-made prostate cancer test could avoid the need for biopsies in four out of five cases, according to a study. The EpiSwitch PSE next generation blood test uses advances in technology to ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

The collaboration includes the initial validation and deployment of Ibex Prostate within HNL Lab Medicine’s LDT workflow.

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

A remarkable scientific advancement could transform how prostate cancer is detected in men around the world. Researchers have developed a groundbreaking urine test that offers significant advantages ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade ...

Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...

Jeffrey Tosoian, MD, assistant professor of Urology and director of Translational Cancer Research at Vanderbilt University Medical Center. The results are important because this could enable at-home ...